Virological and immunological characteristics of HIV treatment failure

被引:21
作者
Kaufmann, D
Muñoz, M
Bleiber, G
Fleury, S
Lotti, B
Martinez, R
Pichler, W
Meylan, P
Telenti, A [1 ]
机构
[1] CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] Univ Bern, Inselspital, Div Allergol, CH-3010 Bern, Switzerland
关键词
MDR-HIV; fitness; immune recovery; infectivity; replication; drug resistance;
D O I
10.1097/00002030-200008180-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Resistance to antiretroviral treatment is prevalent. There is limited knowledge of the determinants of disease evolution in subjects infected with multidrug-resistant HIV (MDR-HIV). Methods: Infectivity, replication, chemokine receptor usage, and env, gag, protease and reverse transcriptase sequence analysis was performed for MDR-HIV isolates from 14 HIV-infected individuals and compared to wild-type HIV isolates from individuals naive to antiretroviral treatment. Expression of CD45RO/RA, Ki67 and interferon-gamma and CD4 proliferative response to various antigens was determined for individuals infected with MDR-HIV and compared to that in individuals with optimal suppression of viral replication. Results: Infectivity and replication are diminished for various MDR-HIV isolates, usually in the context of an increase in CD4 and CD4+CD45RA+ T-cell counts. However, a number of MDR-HIV isolates are associated with high in vivo viraemia and pronounced immunosuppression, and display in vitro levels of infectivity and replication comparable to those of wild-type strains. No specific genetic sequence or chemokine receptor usage predicted the fitness of an MDR isolate. Conclusions: Despite the biological diversity of resistant viruses and the range of host responses observed, our descriptive analysis indicates that viral factors play a role in determining the degree of immune damage observed in the context of MDR-HIV infection. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1767 / 1774
页数:8
相关论文
共 21 条
[1]   CENTRIFUGAL ENHANCEMENT OF RETROVIRAL-MEDIATED GENE-TRANSFER [J].
BAHNSON, AB ;
DUNIGAN, JT ;
BAYSAL, BE ;
MOHNEY, T ;
ATCHISON, RW ;
NIMGAONKAR, MT ;
BALL, ED ;
BARRANGER, JA .
JOURNAL OF VIROLOGICAL METHODS, 1995, 54 (2-3) :131-143
[2]   Polymorphism of HIV type 1 Gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors [J].
Bally, F ;
Martinez, R ;
Peters, S ;
Sudre, P ;
Telenti, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) :1209-1213
[3]  
BLEIBER G, 2000, S NOV BIOL APPR HIV
[4]   HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy [J].
Deeks, SG ;
Hecht, FM ;
Swanson, M ;
Elbeik, T ;
Loftus, R ;
Cohen, PT ;
Grant, RM .
AIDS, 1999, 13 (06) :F35-F43
[5]  
Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001
[6]  
*DIV AIDS I ALL IN, 1997, VIR MAN HIV LAB
[7]   Changes in thymic function with age and during the treatment of HIV infection [J].
Douek, DC ;
McFarland, RD ;
Keiser, PH ;
Gage, EA ;
Massey, JM ;
Haynes, BF ;
Polis, MA ;
Haase, AT ;
Feinberg, MB ;
Sullivan, JL ;
Jamieson, BD ;
Zack, JA ;
Picker, LJ ;
Koup, RA .
NATURE, 1998, 396 (6712) :690-695
[8]   Limited CD4+ T-cell renewal in early HIV-1 infection:: Effect of highly active antiretroviral therapy [J].
Fleury, S ;
de Boer, RJ ;
Rizzardi, GP ;
Wolthers, KC ;
Otto, SA ;
Welbon, CC ;
Graziosi, C ;
Knabenhans, C ;
Soudeyns, H ;
Bart, PA ;
Gallant, S ;
Corpataux, JM ;
Gillet, M ;
Meylan, P ;
Schnyder, P ;
Meuwly, JY ;
Spreen, W ;
Glauser, MP ;
Miedema, F ;
Pantaleo, G .
NATURE MEDICINE, 1998, 4 (07) :794-801
[9]   CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART) [J].
Kaufmann, D ;
Pantaleo, G ;
Sudre, P ;
Telenti, A .
LANCET, 1998, 351 (9104) :723-724
[10]  
LECOSSIER D, 2000, 7 C RETR OPP INF SAN